DK1389213T3 - 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser - Google Patents

3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser

Info

Publication number
DK1389213T3
DK1389213T3 DK02761972T DK02761972T DK1389213T3 DK 1389213 T3 DK1389213 T3 DK 1389213T3 DK 02761972 T DK02761972 T DK 02761972T DK 02761972 T DK02761972 T DK 02761972T DK 1389213 T3 DK1389213 T3 DK 1389213T3
Authority
DK
Denmark
Prior art keywords
diazabicyclo
formulations
antiarrhythmic compounds
antiarrhythmic
compounds
Prior art date
Application number
DK02761972T
Other languages
Danish (da)
English (en)
Inventor
Neil Barnwell
Adam Herring
Karin Loevqvist
Annika Bjoere
Lal Cheema
David Cladingboel
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1389213T3 publication Critical patent/DK1389213T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02761972T 2001-04-12 2002-04-12 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser DK1389213T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms

Publications (1)

Publication Number Publication Date
DK1389213T3 true DK1389213T3 (da) 2006-07-10

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02761972T DK1389213T3 (da) 2001-04-12 2002-04-12 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser

Country Status (30)

Country Link
US (1) US7217708B2 (et)
EP (2) EP1550663A1 (et)
JP (1) JP2004525970A (et)
KR (1) KR20030087078A (et)
CN (1) CN1269823C (et)
AR (1) AR035452A1 (et)
AT (1) ATE323095T1 (et)
BR (1) BR0208829A (et)
CA (1) CA2443470A1 (et)
CZ (1) CZ20032760A3 (et)
DE (1) DE60210598T2 (et)
DK (1) DK1389213T3 (et)
EE (1) EE200300504A (et)
ES (1) ES2261721T3 (et)
HK (1) HK1061026A1 (et)
HU (1) HUP0303487A3 (et)
IL (1) IL158250A0 (et)
IS (1) IS6980A (et)
MX (1) MXPA03009206A (et)
NO (1) NO20034527L (et)
NZ (1) NZ528560A (et)
PL (1) PL367179A1 (et)
PT (1) PT1389213E (et)
RU (1) RU2286993C2 (et)
SE (1) SE0101327D0 (et)
SK (1) SK12572003A3 (et)
TW (1) TWI237025B (et)
UA (1) UA74629C2 (et)
WO (1) WO2002083688A1 (et)
ZA (1) ZA200307759B (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AU2006258293B2 (en) * 2005-06-13 2010-06-17 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
BRPI0611839A2 (pt) * 2005-06-20 2016-08-30 Astrazeneca Ab processos para a preparação de um sal de ácido sulfônico e para a preparação de um composto, e, mistura
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
EP2001881A2 (en) * 2006-03-07 2008-12-17 Endacea, Inc. Compositions and methods for treating respiratory disorders
EP2327696A1 (en) 2006-06-26 2011-06-01 Warner Chilcott Company, LLC Prolyl hydroxylase inhibitors and methods of use
MX2013014310A (es) 2011-06-06 2014-01-23 Akebia Therapeutics Inc Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer.
NO2686520T3 (et) 2011-06-06 2018-03-17
NZ753905A (en) 2013-06-13 2020-07-31 Akebia Therapeutics Inc Compositions and methods for treating anemia
TWI788702B (zh) 2013-11-15 2023-01-01 美商阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
US11713298B2 (en) 2018-05-09 2023-08-01 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
TWI237025B (en) 2005-08-01
WO2002083688A1 (en) 2002-10-24
ATE323095T1 (de) 2006-04-15
SK12572003A3 (sk) 2004-07-07
IS6980A (is) 2003-10-08
BR0208829A (pt) 2004-03-09
EE200300504A (et) 2003-12-15
IL158250A0 (en) 2004-05-12
DE60210598T2 (de) 2007-02-08
EP1389213B1 (en) 2006-04-12
CN1514837A (zh) 2004-07-21
PT1389213E (pt) 2006-07-31
MXPA03009206A (es) 2004-01-29
CA2443470A1 (en) 2002-10-24
KR20030087078A (ko) 2003-11-12
RU2286993C2 (ru) 2006-11-10
UA74629C2 (en) 2006-01-16
HUP0303487A3 (en) 2005-04-28
NO20034527D0 (no) 2003-10-09
JP2004525970A (ja) 2004-08-26
ES2261721T3 (es) 2006-11-16
RU2003129231A (ru) 2005-04-10
DE60210598D1 (de) 2006-05-24
AR035452A1 (es) 2004-05-26
PL367179A1 (en) 2005-02-21
CZ20032760A3 (cs) 2004-01-14
SE0101327D0 (sv) 2001-04-12
EP1550663A1 (en) 2005-07-06
US20040143000A1 (en) 2004-07-22
US7217708B2 (en) 2007-05-15
EP1389213A1 (en) 2004-02-18
NZ528560A (en) 2005-05-27
NO20034527L (no) 2003-12-10
HUP0303487A2 (hu) 2004-01-28
HK1061026A1 (en) 2004-09-03
ZA200307759B (en) 2005-01-03
CN1269823C (zh) 2006-08-16

Similar Documents

Publication Publication Date Title
NO20041560L (no) 1,6-nafthyridinderivater som antidiabetiske midler
NO20026030L (no) Pyrrolo[2,3-d]pyramidin-forbindelser som immunosuppresive midler
MXPA03008144A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas.
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
DK1389213T3 (da) 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser
NO20022557D0 (no) 2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
HK1069171A1 (en) Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents.
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
ZA200206779B (en) Solid formulation.
MXPA03009315A (es) 1.3-dionas carbociclicas tiazolil-substituidas como agentes pesticidas.
NO20034529L (no) 3,7-diazabicyklo(3,3,1) - formuleringer som anti-arytmi- forbindelser
NO20034528D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
AU2002331972A1 (en) 3,4-methylenedioxy-substituted chalcones as therapeutic agents
NO20024502L (no) 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
ATE470655T1 (de) Substituierte 1,5-diaminopentan-3-ol-verbindungen
ITRM20000434A0 (it) Procedimento per la preparazione di 9,10-diidro-pirrolo [2,1-b] [1,3]benzotiazepine 9-ammino sostituite.
DK1453820T3 (da) Substituerede 6H-dibenzo{c,h]vhromener som östrogene midler
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen